Treatment · International
JAMA Psychiatry: psilocybin for treatment-resistant depression — the EPISODE randomized trial
A multi-site randomized trial of psilocybin for adults with treatment-resistant major depression.
The EPISODE randomized clinical trial published in JAMA Psychiatry reports on the efficacy and safety of psilocybin in adults with treatment-resistant major depression — an addition to a small but growing body of pivotal psychedelic data.
The paper sits in the middle of the post-MDMA-rejection psychedelic regulatory landscape, where trial design and blinding remain the dominant open questions.
Read the full JAMA Psychiatry article for the methodology and outcomes.
Mental Hum is a reading list, not a publisher. The summary above is our own editorial framing; the reporting and analysis live at the source.
If reading this brought something up for you —
Call or text 988 for the Suicide & Crisis Lifeline. See all crisis resources.